In DR4 transgenic mice a linear peptide malaria vaccine candidate containing QNT-Y elicits higher anti-CS repeat antibody titers than a peptide containing QNT-5 but the effect is transient and long-term responses are reduced. This evidence concerns the gene TNFRSF10A and malaria.